ArticleJournal of gastrointestinal oncology2023

Efficacy and safety of regorafenib as second-line treatment for patients with hepatocellular carcinoma and macrovascular invasion and(or) extrahepatic metastasis.

Yan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.